CCL5 and neoplasm: Furthermore, we explored the impact of the tumor-associated macrophage (TAM) depletion agent, clodronate liposome, and CCL5 neutralization antibody, on the accumulation of OT-I CD8 T cells within the tumor tissues (Fig. 3e).